HER-2 signaling and inhibition in breast cancer. [electronic resource]
Producer: 20090916Description: 419-38 p. digitalISSN:- 1873-5576
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- therapeutic use
- Breast Neoplasms -- drug therapy
- Cell Division
- Cell Survival
- Cell Transformation, Neoplastic
- Clinical Trials as Topic
- Drug Resistance, Neoplasm
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Receptor, ErbB-2 -- antagonists & inhibitors
- Signal Transduction -- physiology
- Trastuzumab
- Up-Regulation
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.